PROGEN and Mitsubishi Chemical Europe GmbH Sign an Exclusive Distribution Contract for the PATHFAST® POCT Analyzing System

Effective immediately, PROGEN Biotechnik GmbH, a subsidiary of november AG, exclusively distributes the PATHFAST® analyzing system of Mitsubishi Chemical Europe GmbH in Germany. The PATHFAST® analyzing system enables effective parallel processing of up to six patient samples or analytes in one run. High precision as well as a fast and easy-to-perform test procedure makes the PATHFAST® the ideal analyzing system on a cardiology, intensive care or an emergency ward, as an adequate 'outpost' of a central laboratory. The PATHFAST® analyzing system allows quantitative and reliable measurements from heparin or EDTA whole blood or plasma in emergency medicine (e.g. myocardial infarction, myocarditis). Available cardiac markers are Troponin I, CK-MB mass, Myoglobin, NT-proBNP as well as hsCRP.

Features of the PATHFAST® analyzing system:

• meets the guideline of the German Cardiac Society (DGK, BNK) for a CV<10% at the 99% percentile for Troponin measurement
• profile of cardiac markers (e.g. cTnI, CK-MB, NT-proBNP) in one test run
• analysis from heparin or EDTA whole blood or plasma
• simultaneous analysis of up to six samples or analytes
• results in 17 minutes
• integrated computer and printer, touch screen operation
• barcode reader, RS-232C interface, LIMS connection, data transfer
• no water connection and buffer system required
• ready-to-use cartridge including all reagents and buffer
• only one cartridge and one pipette tip per test run
• no training required
• attractive leasing offers

With the takeover of the distribution of the PATHFAST® analyzing system, november´s subsidiary PROGEN is expanding its product range in the area of emergency diagnostics. This high-quality analyzing system is an ideal supplement to PROGEN´s own product range which adds growth potential and supports PROGEN´s growth strategy and will contribute to increase sales turnovers.